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Low density lipoprotein (LDL) is retained in the extracel-
lular matrix of the arterial wall where it is considered to 
be atherogenic, but little is known about how cell adhe-
sion to the matrix is affected by collagen-bound LDL. We 
tested the effect of native, oxidized and acetylated LDL 
reacted with adsorbed monomeric type I, III and V colla-
gen on endothelial cell adhesion to collagen using a 
colorimetric adhesion assay. We found that none of the 
LDL species affected adhesion to type I and III collagen, 
but that collagen-bound native and acetylated LDL en-
hanced attachment to type V collagen, whereas bound 
oxidized LDL inhibited adhesion to this collagen. We 
suggest that oxidized LDL associated with type V colla-
gen in the arterial wall would favor de-endothelialization 
and contribute to atherogenesis and thrombosis. 
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Critical interactions between atherogenic lipoproteins, ex-
tracellular matrices and vascular wall cells astutely govern 
the progression of atherosclerotic disease. Atherogenesis is 
especially exacerbated when circulating low density lipopro-
tein (LDL) seeps into the arterial wall and is sequestered in 
the subendothelial matrix. Bound to the matrix, LDL is prone 
to oxidation by reactive oxygen species, peroxynitrite and 
enzymes such as lipoxygenases and myeloperoxidase [1]. 
Oxidized LDL (oxLDL) is particularly atherogenic, because it 
elicits recruitment of blood monocytes into the artery, trans-
formation of macrophages and smooth muscle cells into 
foam cells, cell proliferation, inflammatory responses, and 
changes in cell adhesive properties [2]. Furthermore, oxLDL 
is thought to cause endothelial cell insult and to inhibit re-
endothelialization of injured areas of the arteries [3, 4]. Con-
sequently, accumulation of LDL in the arterial wall contrib-
utes to the development of atherosclerosis and related dis-
eases. 
Although LDL is clearly retained in the extracellular matrix 
both in vivo and in vitro, surprisingly little definitive informa-
tion is available on which specific component LDL reacts 
with, including collagen itself, the major constituent of the 
matrix. The incorporation of LDL into the matrix and its bind-
ing to collagen is thought to be facilitated by intermediaries 
such as lipoprotein lipase [5-9], glycosaminoglycans [10], 
and decorin, a small dermatan sulfate-rich proteoglycan [11], 
and it is likely that additional accessory molecules will be 
discovered. With regard to direct interactions between LDL 
and collagen gels, several experimenters [12-14] viewed type 
I collagen as a major trapper of native LDL (natLDL) and 
especially of oxLDL. In contrast, Pentikainen et al. [11] re-
ported that LDL does not bind appreciably to plastic-
adsorbed type I collagen alone. Greilberger et al. [15] de-
scribed limited association of natLDL with adsorbed type I 
collagen at low ionic strength, but strong binding of oxLDL. 
However, at physiological ion concentration they found that 
both natLDL and oxLDL associate with this collagen in 
equivalent amounts. These binding kinetics have been con-
firmed by Takei et al. [16] for type I collagen gels. NatLDL 
and oxLDL also bind to type III collagen about as well as to 
type I collagen, but both lipoproteins react less avidly with 
type V collagen [14, 15]. Quantitative experimental studies 
on interactions between type V collagen and various forms of 
LDL are lacking. 
Since subendothelial matrix-bound LDL is thought to pro-
foundly affect numerous aspects of cell behavior including 
adhesion, we studied the attachment of endothelial cells to 
plastic-adsorbed type I, III and V collagen that had been 
reacted with natLDL, oxLDL or acetylated LDL (acLDL) 
following adsorption. We reasoned that the LDL modifica-
tions might elicit specific differences in cell adhesion. We 
found that type V collagen and LDL together constitute a 
hitherto unrecognized biologically active adhesive substrate 





Cell culture – Endothelial cells were isolated enzymatically 
from bovine aortas obtained from a slaughterhouse using 
established procedures and were characterized by staining 
of von Willebrand factor. They were cultivated in DMEM with 
10% FCS under 5% CO2 at 37°C. Cells passaged less than 
ten times and grown to subconfluency were used. 
 
Collagen preparation – Type I and type III collagen were 
isolated from calf skin by acid-extraction and limited pepsin 
digestion, respectively, and purified by fractional salt precipi-
tation [17]. Type V collagen, obtained from bovine amnion by 
pepsin digestion, was first purified as described by Rhodes & 
Miller [18]. The final precipitate described by the authors was 
solubilized in 0.02 mol/L sodium acetate, pH 4.8, and chro-
matographed on a Whatman CM-52 cation exchange column 
(Biometra, Göttingen, Germany). The two chain form of type 
V collagen, [α1(V)]2α2(V), was eluted in a single peak follow-
ing type IV collagen using a 0-0.1 mol/L NaCl gradient. Puri-
fied collagens were tested for homogeneity using polyacryl-
amide gel electrophoresis, lyophilized and stored at -20°C. 
 
Isolation and modification of LDL – NatLDL in the density 
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plasma by sequential differential ultracentrifugation and 
dialyzed extensively against 0.15 mol/L NaCl with 5 mmol/L 
EDTA and then against 0.15 mol/L NaCl. OxLDL was made 
by oxidizing natLDL for 6 hours at 37°C using copper sulfate 
[19]. The oxidation status of oxLDL was estimated on the 
basis of the amount of thiobarbituric acid-reactive sub-
stances present as described by Thomas & Jackson [20]. 
The oxLDL used contained an equivalent of about 5 nM 
malondialdehyde/mg protein and thus was weakly oxidized 
(data not shown). AcLDL was obtained by reacting natLDL 
with acetic anhydride [21]. Completeness of acetylation was 
verified by agarose gel electrophoresis. The finished prod-
ucts were sterile-filtered and stored at 4°C for no longer than 
nine days before use. 
 
Coating of microtiter plates – Lyophilized collagen was 
solubilized in 0.1% acetic acid at a concentration of 1 mg/ml 
and adsorbed to 96-well Polysorb microtiter plates (Nunc, 
Wiesbaden, Germany) overnight at 4°C at six successive 
three-fold dilutions from 10 to 0.04 µg/ml in volumes of 100 µl 
per well. Two wells were used per collagen type and concen-
tration in each experiment. Following adsorption, the plates 
were washed with water, blocked with 0.5% BSA and 
washed again. The adsorbed collagen in the wells was incu-
bated with 100 µl per well of the LDL preparations diluted in 
Dulbecco's PBS without calcium and magnesium chloride 
(Sigma, Deisenhofen, Germany) to a protein concentration of 
100 µg/ml or with 100 µl of neat PBS overnight at 4°C. The 
plates were washed again and used immediately for the 
adhesion tests. 
 
Cell adhesion assay – Cultivated cells were suspended by 
trypsinization and washed with serum-free DMEM to mini-
mize interference by serum proteins during attachment. 
Approximately 40,000 cells in 100 µl of serum-free medium 
were added to each well and allowed to attach at 37°C for 3 
hours. The plates were carefully washed twice by hand with 
PBS to remove non-adherent cells. The relative number of 
cells in each well was assayed colorimetrically using a MR 
5000 plate reader (Dynatech, Krefeld, Germany) essentially 
as described by Kueng et al. [22], except that 1% toluidine 
blue in PBS was used for staining and that extinctions were 
measured at 590 nm. Measured extinctions were linearly 
proportional to cell numbers in the range of 2,000 to at least 




The adhesion of endothelial cells to increasing amounts of 
adsorbed type I, III and V collagen reacted with natLDL, 
oxLDL or acLDL and to the same concentrations of ad-
sorbed, unreacted collagens was analyzed. All solutions from 
which the collagens were adsorbed contained pure collagen 
molecules as shown by polyacrylamide gel electrophoresis 
under non-reducing and reducing conditions (Figure 1) in 
monomeric form as assessed by rotary shadowing and 
electron microscopy (data not shown). The adhesion experi-
ments were repeated four times. Examination of the extinc-
tion curves for type I and III collagen with and without LDL 
showed that adhesion rose rapidly with the amount of colla-
gen in the adsorption solution, reaching saturation at a colla-
gen concentration of < 2 µg/ml. Therefore, to pool the results, 
all extinction data for each experiment were scaled by a 
factor such that the average of the extinctions for those wells 
containing pure type I collagen at the concentrations 3.33 
and 10 µg/ml (four values) corresponded to 1. The adjusted 
experimental data, scaled in this way and pooled over the 














Figure 1: SDS polyacrylamide gel electrophoresis of collagens type I, II and 
V preparations used in the adhesion experiments. The preparations show the 
expected pattern of each of the single collagen polypeptide chains as described 
by Rhodes & Miller [18]. Bands not labeled in this figure represent oligomers of 





Comparison of the adhesion curves in Figure 2.A and 2.B 
shows that endothelial cells adhered about as readily to type 
I as to type III collagen regardless of whether the collagen 
had been reacted with LDL or not; collagen-bound LDL had 
no effect on adhesion to these collagens. In comparison to 
type I and III collagen, the affinity of the cells to type V colla-
gen was significantly lower for all substrates and for all colla-
gen coating concentrations tested (p < 0.01) except the 
lowest, 0.04 µg/ml (cf. Figures 2.A and 2.B with 2.C). Satura-
tion of adhesion for cells on type V collagen was reached 
more slowly and at noticeably higher collagen concentrations 
(>3 µg/ml) than for cells on the other collagens. Moreover, 
adhesion to type V collagen was strongly dependent both on 
the presence of collagen-bound LDL and on the composition 
of the LDL (Figure 2.C); compared to adhesion to the pure 
collagen alone, adhesion to type V collagen was elevated in 
the presence of natLDL and especially of acLDL, and com-
pared to natLDL, oxLDL inhibited endothelial cell adhesion to 
type V collagen, whereas acLDL enhanced adhesion. To 
quantify these relationships, we calculated the percentages 
of cells adhering to type V collagen with oxLDL and acLDL 
relative to the number of cells that adhered to type V colla-
gen with natLDL for the two collagen concentrations (3.33 
and 10 µg/ml) at which adhesion approached maximum 
(Table 1). Only about two thirds as many cells adhered to 
type V collagen with associated oxLDL as to collagen with 
natLDL, whereas approximately one quarter more cells 
adhered to collagen with acLDL than to collagen with 
natLDL. These differences were significant at the levels 
indicated in Table 1. Approximately twice as many cells 
adhered to collagen with acLDL as to collagen with oxLDL (p 
< 0.001; Figure 2.C). 
 
 
Table 1: Endothelial cells adhering to adsorbed type V collagen reacted 
with oxidized low density lipoprotein (oxLDL) and acetylated low density 
lipoprotein (acLDL) relative to cells adhering to collagen reacted with native 
low density lipoprotein (natLDL). 
 
Concentration natLDL oxLDL acLDL 
µg/ml % % % 
3.33 100 70* 135* 
10 100 68‡ 120† 
 
Probabilities of the observed number of adhering cells being the same as the 
number of cells that adhered to collagen with natLDL,* p < 0.01, † p < 0.05, ‡ p < 
0.001, were estimated using Student's t-test. Concentrations given refer to the 
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4 DISCUSSION 
We examined whether adhesion of vascular endothelial cells 
to adsorbed monomeric interstitial collagen is altered when 
LDL is complexed with the collagen. Adhesion to type I and 
III collagen is not affected by collagen-bound LDL. In con-
trast, adhesion to type V collagen is strongly influenced by 
the presence of LDL and by the composition of the LDL. 
Most importantly, adhesion is significantly inhibited by colla-
gen-bound oxLDL compared to adhesion to this collagen with 
associated natLDL. We conclude that endothelial cell ad-
hesion to type V collagen is modified by collagen-bound LDL. 
Our studies reveal effects of collagen-bound LDL on ad-
hesion, but they do not clarify whether endothelial cell at-
tachment takes place to collagen, LDL, or both, or indirectly 
via other molecules. Although the cells were allowed to 
adhere for only a short time (3 hours) and in a serum-
deficient environment, they may have been able to mobilize 
sufficient quantities of accessory molecules that might also 
play a role in attachment. Nevertheless, endothelial cell 
adhesion to the type I and III collagen substrates evidently 
does not depend on LDL and its receptors [23,24], because 
the kinetics of attachment to bare type I and III collagen and 
to these collagens with associated LDL are the same. A 
common receptor for both collagen and LDL, such as CD36 
[25], might be involved. It is also possible that insufficient 
amounts of LDL bind to type I and type III collagen to influ-
ence adhesion noticeably. On the other hand, LDL is re-
ported to have substantially higher affinity for type I collagen 
than for type V collagen [14, 15], and as we have shown, 
adhesion to type V collagen is clearly influenced by collagen-
bound LDL. The observed differences in adhesion to type V 
collagen with LDL might be due to variations in the amounts 
of collagen-bound LDL and consequent differential masking 
of collagen-cell binding sites by the LDL, but we consider this 
explanation unlikely, because adhesion was enhanced by 
natLDL and acLDL compared to adhesion to the collagen 
alone. We conclude that the modalities of adhesion to type I 




Figure 2: Kinetics of adhesion of endothelial cells to collagen with and 
without (w/o) collagen-bound low density lipoprotein (LDL). Cells were 
allowed to attach to microtiter plates with adsorbed collagen that had been 
reacted with LDL. Relative numbers of adhering cells were estimated colorimetri-
cally. Extinction is in arbitrary units. The x-axis gives the collagen concentration 
in the coating solutions (means ± SEM; n = 8 for each concentration). (A, B) Lack 
of effect of any kind of LDL on adhesion to type I and III collagen. (C) Enhance-
ment of adhesion to type V collagen by collagen-bound native LDL (natLDL) and 






Viewed in the context of the artery, modification of adhesion 
to type V collagen by LDL could obviously have a bearing on 
the adhesiveness of endothelial cells to the subendothelium. 
Type V collagen has traditionally been regarded as a regula-
tor of collagen fibrillogenesis [26, 27]. However, this collagen 
also influences cell adhesion strongly, because endothelial 
cells, platelets, monocytes and smooth muscle cells adhere 
less to it than to the other fibril-forming collagens in vitro [28-
31], and coatings of type V collagen inhibit endothelialization 
of prothetic surfaces [32]. Accordingly, type V collagen is 
considered antithrombogenic. Our own adhesion tests on 
human and porcine smooth muscle cells revealed just base-
line attachment to this collagen with or without LDL, and in 
marked contrast to endothelial cells, no modification of adhe-
sion whatsoever with natLDL or acLDL (data not shown). 
Type V collagen generally comprises only a few percent of 
the interstitial collagen in the normal artery, but it is en-
hanced under pathologic conditions [33]. It represents a 
major expressed collagen in cultured endothelial cells which 
secrete it predominantly into the cell layer and not into the 
medium, as is the case for type III collagen [34]. Using im-
munohistochemistry and an anti-type V collagen antibody 
(clone V-3C9; ICN, Aurora, Ohio), we have seen strong 
expression of type V collagen in and near the human arterial 
endothelium (data not shown). Hence, the basal surfaces of 
endothelial cells in the artery would be expected to be exten-
sively exposed to this collagen. OxLDL accumulated in the 
subendothelium would also be expected to interact baso-
laterally with endothelial cells [16]. Along with oxLDL and 
other collagens, type V collagen is present in substantial 
quantities in atherosclerotic plaques [35, 36]. As we have 
shown, endothelial cell adhesion to type V collagen is inhib-
ited by collagen-bound oxLDL. Thus, acting in concert, type 
V collagen with bound oxLDL would tend to impair endothe-
lial cell adhesion in the endothelium. We think that the known 
toxic effect of oxLDL may be related to inhibition of adhesion 
of endothelial cells to the subendothelial matrix as a result of 
the association of oxLDL with type V collagen. 
We speculate that reduction in endothelial cell adhesion to 
type V collagen due to collagen-bound oxLDL might be one 
factor promoting de-endothelialization in the hyperlipidemic 
artery. This may be an initial and crucial event in arterial 
injury. Conversely, the enhanced attachment to type V colla-
gen with bound natLDL seen by us may represent the basal 
adhesion level to this collagen in the in vivo situation where 
natLDL and type V collagen complexed with type I collagen 
would always be present. To summarize, type V collagen 
with bound oxLDL would be atherogenic. The de-
endothelializing tendency of oxLDL bound to type V collagen 
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